|
Mobile & Wireless
New wireless diabetes management system aids diabetic monitoring
Diabetech collaborates with Cinterion Wireless Modules to power GlucoMON
by TelecomEngine Newsdesk
Cinterion Wireless Modules and Diabetech recently announced their collaboration on the fourth generation GlucoMON platform, a wireless diabetes management system designed to help diabetics manage their specialized health requirements. The 4th generation GlucoMON device uses Cinterion’s TC65 Terminal and works in conjunction with Diabetech’s Automated Diabetes Management System (ADMS) data to help manage and control blood glucose levels and change behavior to avoid diabetic complications. The technology platform operates on the AT&T and T-Mobile cellular networks worldwide.
The GlucoMON appliance is a component in Diabetech’s ADMS; a patient-centric diabetes education and management platform with 24-7, real time worldwide support. By connecting a blood glucose meter to the GlucoMON, which utilizes Cinterion’s TC65 Terminal, a series of automated care algorithms are triggered in the remote data center that analyze information and deliver timely feedback that help users bring blood sugar levels back to a normal range.
“GlucoMON-ADMS is the perfect example of how smart M2M wireless technology can help improve quality of life, making disease management easier and ultimately making people healthier,” said Peter Fowler, regional president, Cinterion Wireless Modules, Americas.
The platform distinguishes individual patient profiles and issues and is used in a variety of ways – by adults to simplify their own efforts to maintain healthy blood glucose levels; by concerned parents who receive automated notifications of their child’s blood sugar levels while they are away at a school; and by pregnant mothers with a temporary form of the disease who depend on their doctors and nurses to guide them through a sharp learning curve. When prudent, GlucoMON-ADMS automatically connects the patient to family members, Diabetech's diabetes educators or any number of outpatient diabetes programs.
“In the past eight years working on more than a dozen clinical trials and many system refinements, we’ve created an intuitive health platform that simplifies patient tasks, creates more efficiencies for providers, significantly improves blood sugar control and decreases costs to the health care system at large,” said Kevin McMahon, Diabetech’s CEO. “We selected Cinterion for their market leading expertise and high quality M2M products that allowed us to quickly and easily migrate away from previous networks and scale the platform with confidence.”
Telehealth M2M products such as GlucoMON-ADMS are a growing market segment for their ability to cut medical costs and help manage chronic disease. A study released this summer by ABI Research projects that there will be approximately 15 million wireless telehealth sensors and devices in use by 2012, or more than double the number of wireless telehealth systems in use today.
|
